Cargando…
Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients
Bisphosphonates are well known inhibitors of osteoclast activity and thus may be employed to influence osteoblast activity. The present study was designed to evaluate the in vivo effects of zoledronic acid (ZA) on the proliferation and osteoblastic commitment of mesenchymal stem cells (MSC) in osteo...
Autores principales: | Dalle Carbonare, Luca, Mottes, Monica, Malerba, Giovanni, Mori, Antonio, Zaninotto, Martina, Plebani, Mario, Dellantonio, Alessandra, Valenti, Maria Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486083/ https://www.ncbi.nlm.nih.gov/pubmed/28608802 http://dx.doi.org/10.3390/ijms18061261 |
Ejemplares similares
-
Osteogenic Differentiation in Healthy and Pathological Conditions
por: Valenti, Maria Teresa, et al.
Publicado: (2016) -
Ectopic expression of the osteogenic master gene RUNX2 in melanoma
por: Valenti, Maria Teresa, et al.
Publicado: (2018) -
Effects of Oral Anticoagulant Therapy on Gene Expression in Crosstalk between Osteogenic Progenitor Cells and Endothelial Cells
por: Dalle Carbonare, Luca, et al.
Publicado: (2019) -
Role of autophagy in bone and muscle biology
por: Valenti, Maria Teresa, et al.
Publicado: (2016) -
Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
por: Dalle Carbonare, Luca, et al.
Publicado: (2021)